Claudia Burz

923 total citations
42 papers, 678 citations indexed

About

Claudia Burz is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Claudia Burz has authored 42 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 16 papers in Molecular Biology and 13 papers in Cancer Research. Recurrent topics in Claudia Burz's work include Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (7 papers) and Circular RNAs in diseases (6 papers). Claudia Burz is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (7 papers) and Circular RNAs in diseases (6 papers). Claudia Burz collaborates with scholars based in Romania, Australia and Italy. Claudia Burz's co-authors include Alexandru Irimie, Ovidiu Bălăcescu, Ioana Ilie, Daniel Sur, Gabriel Samaşcă, Iulia Lupan, Patriciu Achimaș-Cădariu, Călin Cainap, Rareş Buiga and Cornel Aldea and has published in prestigious journals such as Annals of Oncology, Oncotarget and Cancers.

In The Last Decade

Claudia Burz

42 papers receiving 659 citations

Peers

Claudia Burz

ONCOL

PRM

PFM

Youqun Xiang China

Jiege Huo China

Neha Merchant India

Fuwen Luo China

Zhiyun Cao China

Lei Tian China

Xiumei Zheng China

Ko‐Chao Lee Taiwan

Nethaji Muniraj United States

Ji Ma China

Youqun Xiang China

Claudia Burz

347 ×1.2

250 ×1.1

ONCOL

150 ×1.0

73 ×0.7

PRM

84 ×1.0

PFM

Citations per year, relative to Claudia Burz Claudia Burz (= 1×) peers Youqun Xiang

Countries citing papers authored by Claudia Burz

Since Specialization

Citations

This map shows the geographic impact of Claudia Burz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Burz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Burz more than expected).

Fields of papers citing papers by Claudia Burz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Burz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Burz. The network helps show where Claudia Burz may publish in the future.

Co-authorship network of co-authors of Claudia Burz

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Burz. A scholar is included among the top collaborators of Claudia Burz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Burz. Claudia Burz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burz, Claudia, et al.. (2024). Helicobacter pylori Infection in Patients with Gastric Cancer: A 2024 Update. Cancers. 16(11). 1958–1958. 3 indexed citations

Burz, Claudia, et al.. (2024). Prognosis and Treatment of Gastric Cancer: A 2024 Update. Cancers. 16(9). 1708–1708. 26 indexed citations

Bințințan, Vasile, et al.. (2024). The Importance of Extracellular Vesicle Screening in Gastric Cancer: A 2024 Update. Cancers. 16(14). 2574–2574. 3 indexed citations

Pop, Raluca Maria, et al.. (2023). 5-fluorouracil therapeutic drug monitoring and adverse events in a Romanian population. Medicine and Pharmacy Reports. 96(4). 413–419. 2 indexed citations

Sur, Daniel, et al.. (2022). Long Term Administration of Nivolumab for Metastatic Melanoma: A Case Report. Cureus. 14(6). e26359–e26359. 1 indexed citations

Sur, Daniel, et al.. (2022). Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic review. Medicine and Pharmacy Reports. 95(3). 251–259. 3 indexed citations

Cismaru, Gabriel, Paul-Mihai Boarescu, Alina Gabriela Negru, et al.. (2021). ECG Markers of Cardiovascular Toxicity in Adult and Pediatric Cancer Treatment. Disease Markers. 2021. 1–10. 17 indexed citations

Sur, Daniel, Loredana Bălăcescu, Simona Căinap, et al.. (2021). Predictive Efficacy of MiR-125b-5p, MiR-17-5p, and MiR-185-5p in Liver Metastasis and Chemotherapy Response Among Advanced Stage Colorectal Cancer Patients. Frontiers in Oncology. 11. 651380–651380. 18 indexed citations

Cismaru, Cosmin Andrei, Olga Şoriţău, Ancuța Jurj, et al.. (2020). Human Chorionic Gonadotropin Improves the Proliferation and Regenerative Potential of Bone Marrow Adherent Stem Cells and the Immune Tolerance of Fetal Microchimeric Stem Cells In Vitro. Stem Cell Reviews and Reports. 16(3). 524–540. 5 indexed citations

10.

Burz, Claudia, et al.. (2020). Fluoropyrimidine-induced cardiotoxicity. World Journal of Clinical Oncology. 11(12). 1008–1017. 11 indexed citations

11.

Burz, Claudia, et al.. (2020). A review on the importance of genotyping and phenotyping in fluoropyrimidine treatment. Medicine and Pharmacy Reports. 93(3). 223–230. 11 indexed citations

12.

Sur, Daniel, Genel Sur, Cornel Aldea, et al.. (2019). MiRNAs roles in the diagnosis, prognosis and treatment of colorectal cancer. Expert Review of Proteomics. 16(10). 851–856. 19 indexed citations

13.

Burz, Claudia, Rareş Buiga, Cornel Aldea, et al.. (2019). Liquid biopsy challenge and hope in colorectal cancer. Expert Review of Molecular Diagnostics. 19(4). 341–348. 9 indexed citations

14.

Burz, Claudia, Anca Bojan, Loredana Bălăcescu, et al.. (2019). Interleukin 8 as predictive factor for response to chemotherapy in colorectal cancer patients. Acta Clinica Belgica. 76(2). 113–118. 8 indexed citations

15.

Lazăr, Florin-Leontin, Diana Olteanu, Claudia Burz, et al.. (2019). Solid Lipid Nanoparticles: Vital Characteristics and Prospective Applications in Cancer Treatment. Critical Reviews in Therapeutic Drug Carrier Systems. 36(6). 537–581. 20 indexed citations

16.

Seicean, Andrada, et al.. (2019). Interleukin-6 correlated with neutrophil-to-lymphocyte ratio in pancreatic cancer. Annals of Oncology. 30. iv15–iv16. 4 indexed citations

17.

Burz, Claudia, Loredana Bălăcescu, Rareş Buiga, et al.. (2016). TUMOR MARKERS USED IN MONITORING THE TUMOR RECURRENCE IN PATIENTS WITH COLORECTAL CANCER. Medicine and Pharmacy Reports. 89(3). 378–383. 4 indexed citations

18.

Fischer‐Fodor, Eva, Corina Tatomir, Maria Perde‐Schrepler, et al.. (2015). Vitis vinifera seeds extract for the modulation of cytosolic factors Bax-α and NF-kB involved in UVB-induced oxidative stress and apoptosis of human skin cells. Medicine and Pharmacy Reports. 89(1). 72–81. 21 indexed citations

19.

Silvestris, Nicola, Ilaria Marech, Anna Elisabetta Brunetti, et al.. (2014). Predictive factors to targeted treatment in gastrointestinal carcinomas. Cancer Biomarkers. 14(2-3). 151–162. 3 indexed citations

20.

Irimie, Alexandru, Ovidiu Bălăcescu, Claudia Burz, et al.. (2011). Prognostic significance of the serum level of different growth factors and their correlation with estrogen receptors in patients with locally advanced breast cancer. ROMANIAN BIOTECHNOLOGICAL LETTERS. 16(5). 6523–6534. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact